Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
Mar, 21 2025
Dec, 16 2025
Nov, 1 2025
Dec, 9 2025
Nov, 13 2025